Nasdaq Delisting Threat Looms as DNA X Secures $3.05M Convertible Note
SONM sits 61% above its 52-week low of $2.521.
Summary
DNA X received a Nasdaq delisting notice for failing to meet equity requirements, while simultaneously securing a $3.05 million convertible note, including $1.8 million in new cash, to fund working capital and address financial distress.
Key Events · Legal and Risk Events · SONM
-
Nasdaq Delisting Notice Received
The company received a delisting determination letter from Nasdaq on May 22, 2026, for failing to meet the $2.5 million stockholders' equity requirement, reporting a $983,000 deficit in its Q1 2026 10-Q. The company intends to appeal, which will temporarily stay the delisting.
-
$3.05 Million Convertible Note Issued
DNA X entered into a Securities Purchase Agreement to issue a convertible promissory note with a principal amount of $3,052,787.68. This includes $1.8 million in new cash and the surrender of an existing $1.2 million convertible note plus accrued interest. The note is convertible at $6.00 per share, subject to stockholder approval, but the conversion price drops to 80% of the closing price during an Event of Default.
-
Note Secured by Subsidiary Assets
The convertible note is secured by a first priority lien and security interest in the company's wholly-owned subsidiary, DNA X, LLC, providing strong protection for the lender.
-
Prior Put Option Terminated
Concurrently with the financing, the company and the purchaser agreed to terminate a 'Put Option' from a December 2025 acquisition, removing a potential liability that allowed the seller to exchange shares for the subsidiary's equity under certain conditions.
Analysis · SONM · Manufacturing
DNA X, a micro-cap company, faces an imminent Nasdaq delisting due to non-compliance with the $2.5 million stockholders' equity requirement, reporting a $983,000 deficit. While the company plans to appeal, the outcome is uncertain and a delisting could severely impact its ability to raise capital and trade shares. Concurrently, the company secured a $3.05 million convertible promissory note, which includes $1.8 million in new cash and the conversion of an existing $1.2 million note plus accrued interest. This financing is critical for working capital, especially given the company's prior 'going concern' warning. The note's conversion price of $6.00 per share is at a premium to the current stock price, but it is contingent on stockholder approval and includes a 'death spiral' clause if an Event of Default occurs. The termination of a prior 'Put Option' also removes a potential liability for the company.
How filings like this one have moved
In the 30 days to Aug 26, 2026, 43.5% of the 1024 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SONM was trading at $4.07 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $2.52 to $38.52. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.